Genetic testing firm 23andMe said on Sunday it filed for filed for Chapter 11 bankruptcy protection in the U.S. to help the $50 million company sell itself and that co-founder and CEO Anne Wojcicki had resigned after multiple failed takeover bids.
The latest offer valued 23andMe at about $11 million, below its current value of $50 million, per LSEG data, and a far cry from its $3.5 billion market capitalization when it went public in 2021.